Cellular Immunotherapy for Septic Shock: A Phase I Trial

NCT02421484 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock

Interventions

BIOLOGICAL: Allogeneic mesenchymal stromal cells

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]